Russian original anticoagulant DIMOLEGIN® presented at the 10th Eastern Economic Forum

The drug was presented on September 4, 2025, during the ceremony for the opening of new major infrastructure facilities in the Far East, held as part of the Eastern Economic Forum (EEF) and attended by Russian President Vladimir Putin.

DIMOLEGIN® is the first Russian-developed oral anticoagulant, a factor Xa inhibitor, included in the List of Vital and Essential Drugs. Preclinical and clinical studies have proven its efficacy and safety.

Clinical studies on the use of DIMOLEGIN® for the prevention of thrombosis after joint replacement surgeries have been successfully completed. Expanding the drug's indications for use in cardiology will provide safe and effective treatment for even more patients.

Video

Photo: a still from the «Russia 24» TV channel broadcast covering the ceremony for the opening of new major infrastructure facilities in the Far East as part of the EEF, attended by Russian President Vladimir Putin.